Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
How to track NASA’s Artemis II and Orion’s journey to the moon - 2See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- 3This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
- 4IDF kills four terrorists equipped with weapons, surveillance gear near Gaza's Yellow Line
- 5Apollo's impatient old-timers are rooting for NASA's return to the moon with Artemis II launch
- New science points to 4 distinct types of autism
- Hilary Duff's husband responds to Ashley Tisdale's 'toxic' mom group claims: The drama, explained
- Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A.
- This professional Santa's dream of spreading holiday cheer fuels stroke recovery
- Best Pizza Beating: What's Your #1?
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- Without evidence, CDC changes messaging on vaccines and autism
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- Astonishing interstellar comet captured in new images by NASA Mars missions
